173 related articles for article (PubMed ID: 16863483)
21. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.
Antignac M; Hulot JS; Boleslawski E; Hannoun L; Touitou Y; Farinotti R; Lechat P; Urien S
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):409-16. PubMed ID: 15991041
[TBL] [Abstract][Full Text] [Related]
24. Estimation of Tacrolimus Clearance in Saudi Adult Kidney Transplant Recipients.
Alqahtani S; Alenazi M; Alsultan A; Alsarhani E
Saudi J Kidney Dis Transpl; 2021; 32(1):101-110. PubMed ID: 34145119
[TBL] [Abstract][Full Text] [Related]
25. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.
Han N; Yun HY; Hong JY; Kim IW; Ji E; Hong SH; Kim YS; Ha J; Shin WG; Oh JM
Eur J Clin Pharmacol; 2013 Jan; 69(1):53-63. PubMed ID: 22660440
[TBL] [Abstract][Full Text] [Related]
26. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
Zhang XQ; Wang ZW; Fan JW; Li YP; Jiao Z; Gao JW; Peng ZH; Liu GL
Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients.
Sun B; Li XY; Gao JW; Rui JZ; Guo YK; Peng ZH; Liu GL
Ther Drug Monit; 2010 Dec; 32(6):715-22. PubMed ID: 21068646
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus population pharmacokinetics according to CYP3A5 genotype and clinical factors in Chinese adult kidney transplant recipients.
Zhang HJ; Li DY; Zhu HJ; Fang Y; Liu TS
J Clin Pharm Ther; 2017 Aug; 42(4):425-432. PubMed ID: 28401703
[TBL] [Abstract][Full Text] [Related]
29. Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.
Li ZR; Li RD; Niu WJ; Zheng XY; Wang ZX; Zhong MK; Qiu XY
J Clin Pharmacol; 2023 Mar; 63(3):314-325. PubMed ID: 36097320
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics of immediate- and prolonged-release tacrolimus formulations in liver, kidney and heart transplant recipients.
Lu Z; Bonate P; Keirns J
Br J Clin Pharmacol; 2019 Aug; 85(8):1692-1703. PubMed ID: 30950096
[TBL] [Abstract][Full Text] [Related]
31. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
Benkali K; Prémaud A; Picard N; Rérolle JP; Toupance O; Hoizey G; Turcant A; Villemain F; Le Meur Y; Marquet P; Rousseau A
Clin Pharmacokinet; 2009; 48(12):805-16. PubMed ID: 19902988
[TBL] [Abstract][Full Text] [Related]
32. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics and pharmacogenetics of tacrolimus in healthy Chinese volunteers.
Xue L; Zhang H; Ma S; Rui JZ; Miao LY
Pharmacology; 2011; 88(5-6):288-94. PubMed ID: 22075549
[TBL] [Abstract][Full Text] [Related]
34. A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients.
Lu YX; Su QH; Wu KH; Ren YP; Li L; Zhou TY; Lu W
Acta Pharmacol Sin; 2015 Feb; 36(2):281-8. PubMed ID: 25500866
[TBL] [Abstract][Full Text] [Related]
35. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.
Andrews LM; Hesselink DA; van Schaik RHN; van Gelder T; de Fijter JW; Lloberas N; Elens L; Moes DJAR; de Winter BCM
Br J Clin Pharmacol; 2019 Mar; 85(3):601-615. PubMed ID: 30552703
[TBL] [Abstract][Full Text] [Related]
36. The Population Pharmacokinetic Models of Tacrolimus in Chinese Adult Liver Transplantation Patients.
Zhu L; Wang H; Sun X; Rao W; Qu W; Zhang Y; Sun L
J Pharm (Cairo); 2014; 2014():713650. PubMed ID: 26556199
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetics of cyclosporine in chinese cardiac transplant recipients.
Yin OQ; Lau SK; Chow MS
Pharmacotherapy; 2006 Jun; 26(6):790-7. PubMed ID: 16716132
[TBL] [Abstract][Full Text] [Related]
38. Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based pharmacokinetic models.
Cai XJ; Li RD; Li JH; Tao YF; Zhang QB; Shen CH; Zhang XF; Wang ZX; Jiao Z
Front Pharmacol; 2022; 13():1031969. PubMed ID: 36438793
[No Abstract] [Full Text] [Related]
39. Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients.
Chen L; Lu X; Tan G; Zhu L; Liu Y; Li M
Xenobiotica; 2020 Feb; 50(2):186-191. PubMed ID: 30995884
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.
Prytuła AA; Cransberg K; Bouts AH; van Schaik RH; de Jong H; de Wildt SN; Mathôt RA
Clin Pharmacokinet; 2016 Sep; 55(9):1129-43. PubMed ID: 27138785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
